Home › NDC Lookup › RxCUI directory › RxCUI 1087365

Hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylat... — RxCUI 1087365

Name: Hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl sali… (RxCUI 1087365)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1087365 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1087365

Official nameHyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)2,806 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methenamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

That's a great question. Methenamine isn't used to clear an active infection — it's used to prevent another one from taking hold. Once your other antibiotic has done that job, meth...
Why do I need to take methenamine if my infection is already gone?
Yes, it actually does. Methenamine only converts into its active antibacterial form in acidic urine. Foods and medications that make your urine more alkaline — less acidic — can re...
Does it matter what I eat or drink while I'm on this medication?

📖 Read our full Methenamine guide →

🕸️ Concept Web — How Hyoscyamine sulfate 0.12 MG / methenamine 118 MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule RxCUI 1087365 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 7

The active substance itself — no strength, form, or brand attached yet.
- Hyoscyamine 153970 IN
- Methenamine 6832 IN
- Methylene blue 6878 IN
- Phenyl salicylate 36122 IN
- Sodium phosphate, monobasic 235496 IN
- Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic 1007374 MIN
- Hyoscyamine sulfate 1225 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Uribel 998338 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule 857012 SCDF
- Hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule 2646653 SCDFP
- Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Product 1164652 SCDG
- Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Pill 1164653 SCDG
- Hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Product 2659194 SCDGP
- Hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Pill 2659588 SCDGP
- Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule [Uribel] 998340 SBDF
- Hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule [Uribel] 2657188 SBDFP
- +5 more in this family
Clinical & branded drugs 7

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Hyoscyamine sulfate 0.12 MG 1037233 SCDC
- Methenamine 118 MG 1087364 SCDC
- Methylene blue 10 MG 406045 SCDC
- Phenyl salicylate 36 MG 406046 SCDC
- Sodium phosphate, monobasic 40.8 MG 384927 SCDC
- Hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule [Uribel] 1087367 SBD
- Hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG [Uribel] 1087366 SBDC

Showing up to 8 concepts per family — 23 of 28 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Hyoscyamine sulfate 0.12 MG SCDC · 1037233
Methenamine 118 MG SCDC · 1087364
Methylene blue 10 MG SCDC · 406045
Phenyl salicylate 36 MG SCDC · 406046
Sodium phosphate, monobasic 40.8 MG SCDC · 384927
Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule SCDF · 857012
Hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule SCDFP · 2646653
Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Product SCDG · 1164652
Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Pill SCDG · 1164653
Hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Product SCDGP · 2659194

Brand-Name Concepts

Hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule [Uribel] SBD · 1087367
Hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG [Uribel] SBDC · 1087366
Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule [Uribel] SBDF · 998340
Hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Capsule [Uribel] SBDFP · 2657188
Uribel Oral Product SBDG · 1186524
Uribel Pill SBDG · 1186525
Uribel BN · 998338

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1087365 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
58657-0456-01	100 CAPSULE in 1 BOTTLE (58657-456-01)	Uro-MP	Method Pharmaceuticals, LLC	2014-12-01

Observed labelers: Method Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$1.7658

Range $1.7658–$1.7658 · middle 50% $1.7658–$1.7658 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.